Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (61-70 of 418) with videos related to

Pageof 42
Sort By:
Cutis|July 15, 2006
Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case reportElizabeth Smith, Marsha Gordon, Mark Lebwohl
Pediatrics|May 3, 2007
Therapy for head lice based on life cycle, resistance, and safety considerationsMark Lebwohl, Lily Clark, Jacob Levitt
Journal of Drugs in Dermatology : JDD|June 5, 2023
Biologic Vs Conventional Therapies: Comparing Risk of Psoriasis-Associated ComorbiditiesEvan Darwin, Mark Lebwohl, George Han
Journal of the American Academy of Dermatology|April 20, 2026
Overconfidence in Coded Data for Rare Diseases: A Call for Caution in EHR-Based Dermatologic ResearchDev Patel, Kateryna Karpoff, Mark Lebwohl
Therapeutics and Clinical Risk Management|April 28, 2010
Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasisNora Koutruba, Jason Emer, Mark Lebwohl
European Journal of Dermatology : EJD|September 2, 2003
Potential future dermatological indications for tacrolimus ointmentThomas Ruzicka, Till Assmann, Mark Lebwohl
Cutis|June 18, 2013
Reduced burning and stinging associated with topical application of lactic acid 10% with strontium versus ammonium lactate 12%Madelaine Haddican, Matthew Gagliotti, Mark Lebwohl
American Journal of Clinical Dermatology|December 3, 2014
Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issuesShira Wieder, Marcus Maurer, Mark Lebwohl
International Journal of Dermatology|June 14, 2025
The Efficacy of Dupilumab in Pemphigus VulgarisFoday Koroma, Shivkar Amara, Mark Lebwohl
Expert Opinion on Pharmacotherapy|December 13, 2016
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profileCarle Paul, Bo Bang, Mark Lebwohl
Pageof 42

Showing results (61-70 of 418) with videos related to

Sort By:
Pageof 42
Cutis|July 15, 2006
Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case reportElizabeth Smith, Marsha Gordon, Mark Lebwohl
Pediatrics|May 3, 2007
Therapy for head lice based on life cycle, resistance, and safety considerationsMark Lebwohl, Lily Clark, Jacob Levitt
Journal of Drugs in Dermatology : JDD|June 5, 2023
Biologic Vs Conventional Therapies: Comparing Risk of Psoriasis-Associated ComorbiditiesEvan Darwin, Mark Lebwohl, George Han
Journal of the American Academy of Dermatology|April 20, 2026
Overconfidence in Coded Data for Rare Diseases: A Call for Caution in EHR-Based Dermatologic ResearchDev Patel, Kateryna Karpoff, Mark Lebwohl
Therapeutics and Clinical Risk Management|April 28, 2010
Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasisNora Koutruba, Jason Emer, Mark Lebwohl
European Journal of Dermatology : EJD|September 2, 2003
Potential future dermatological indications for tacrolimus ointmentThomas Ruzicka, Till Assmann, Mark Lebwohl
Cutis|June 18, 2013
Reduced burning and stinging associated with topical application of lactic acid 10% with strontium versus ammonium lactate 12%Madelaine Haddican, Matthew Gagliotti, Mark Lebwohl
American Journal of Clinical Dermatology|December 3, 2014
Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issuesShira Wieder, Marcus Maurer, Mark Lebwohl
International Journal of Dermatology|June 14, 2025
The Efficacy of Dupilumab in Pemphigus VulgarisFoday Koroma, Shivkar Amara, Mark Lebwohl
Expert Opinion on Pharmacotherapy|December 13, 2016
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profileCarle Paul, Bo Bang, Mark Lebwohl
Pageof 42